RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Clinical Pharmacology Quality Assurance for HIV and Related Infectious Diseases Research
DiFrancesco, R., Tooley, K., Rosenkranz, SL., Siminski, S., Taylor, CR., Pande, P., & Morse, GD. (2013). Clinical Pharmacology Quality Assurance for HIV and Related Infectious Diseases Research. Clinical Pharmacology and Therapeutics, 93(6), 479-482. https://doi.org/10.1038/clpt.2013.62
The global HIV epidemic continues to grow in certain regions while contracting in others, necessitating a broadened research agenda, including clinical pharmacology of tuberculosis, hepatitis, malaria, and immune activation/inflammation, underscoring the need for a coordinated quality assurance approach. A comprehensive program has been developed and implemented by the University at Buffalo HIV Clinical Pharmacology Quality Assurance and Quality Control Program, funded by the National Institutes of Health.